Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5322929
Abstract
Background. Anillin (ANLN), a ubiquitously expressed actin‐binding protein, plays a critical tumor‐promoting role in cell growth, migration, and cytokinesis. Numerous studies have suggested that ANLN is upregulated in many cancer types, as well as significantly associated with patient prognosis and malignant cancer characteristics. Herein, we performed an integrated pan‐cancer analysis of ANLN and highlighted its underlying mechanism, which may benefit further exploration of the potential therapeutic options for cancer. Methods. ANLN expression data were extracted from online databases, including TCGA, GTEx, and CCLE databases. The TIMER database was used to study the association between ANLN expression with immune checkpoint genes and immunocyte infiltration. The ScanNeo pipeline was adopted for neoantigen discovery. KEGG analysis and the STRING tool were used to elucidate the potential mechanism of ANLN in cancer development. Results. ANLN is abnormally overexpressed in almost all cancer tissues compared with normal tissues. The high‐ANLN expression level was positively associated with various malignant characteristics, suggesting its potential role in the immune microenvironment and poor prognosis. In addition, ANLN expression was correlated with the number of neoantigens and different phosphorylation pattern in various cancer types, revealing a functional role of genetic mutation accumulation and high phosphorylation in ANLN‐mediated oncogenesis. Moreover, we found that ANLN was an important regulatory factor participating in many signaling events, especially the cell cycle and nucleocytoplasmic transport pathways. Conclusions. ANLN expression is generally overexpressed in various types of cancers, and it may have an important influence on tumor progression and development. ANLN expression is significantly associated with the immune checkpoint biomarkers and tumor immunity. Together, these findings suggest that ANLN may be a predictive marker for patient prognosis across cancers.Keywords
Funding Information
- National Natural Science Foundation of China (81872006, 81902397)
This publication has 42 references indexed in Scilit:
- jvenn: an interactive Venn diagram viewerBMC Bioinformatics, 2014
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- The myriad roles of Anillin during cytokinesisSeminars in Cell & Developmental Biology, 2010
- Anillin: a pivotal organizer of the cytokinetic machineryBiochemical Society Transactions, 2008
- Rho-dependent control of anillin behavior during cytokinesisJournal of Cell Biology, 2008
- Anillin Is a Scaffold Protein That Links RhoA, Actin, and Myosin during CytokinesisCurrent Biology, 2008
- IFN-γ Alters the Response of Borrelia burgdorferi -Activated Endothelium to Favor Chronic InflammationThe Journal of Immunology, 2007
- ANLN Plays a Critical Role in Human Lung Carcinogenesis through the Activation of RHOA and by Involvement in the Phosphoinositide 3-Kinase/AKT PathwayCancer Research, 2005
- The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human TumorsClinical Cancer Research, 2005
- Anillin Binds Nonmuscle Myosin II and Regulates the Contractile RingMolecular Biology of the Cell, 2005